AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
Surgical Science Announces £45.2 Million Acquisition of Intelligent Ultrasound
December 19, 2024 06:55 PM AEDT| By Team Kalkine MediaHighlights,Surgical Science Sweden AB to acquire Intelligent Ultrasound Group plc for £45.2 million in a cash deal.,Acquisition represents a premium of up to 79.3% over Intelligent Ultrasound’s recent share price.,Strategic alignment to strengthen me...
Pfizer Signals Stability with 2025 Growth Guidance Amid Investor Concerns
December 18, 2024 04:27 AM AEDT| By Team Kalkine MediaHighlights:,Revenue Growth Forecast:,Pfizer expects up to 5% revenue growth, aligning with market expectations.,Earnings Outlook Strong:,Per-share earnings are projected to rise by up to 18% next year.,Covid-19 Revenue Steady:,Product revenue from Co...
ANGLE’s Parsortix System Gains Validation in HER2 Breast Cancer Testing
December 13, 2024 09:48 PM AEDT| By Team Kalkine MediaHighlights:,Independent study validates the Parsortix system for HER2-positive breast cancer testing.,HER2 status shifts identified in circulating tumour cells (CTCs), offering new treatment options.,Potential to extend HER2 antibody-drug conjugates...
Genus (LON:GNS) Stock Performance and Recent Developments
December 13, 2024 11:00 AM AEDT| By Team Kalkine MediaHighlights,Genus (GNS) stock has fluctuated between GBX 1,478 and GBX 2,378 over the past year.,The company operates in the animal genetics industry across global markets, including North America and Europe.,Insider trading activity revealed a recent...
Institutional Ownership at PureTech Health plc (LON:PRTC)
December 13, 2024 11:00 AM AEDT| By Team Kalkine MediaHighlights,71% of PureTech Health’s stock is held by institutional investors.,Invesco Ltd. is the largest shareholder with 17% ownership.,Insider ownership stands at £27 million, with the general public owning 12%.,PureTech Health plc (LON:PRTC), a p...
hVIVO Publishes World-First COVID-19 Characterisation Study in Nature Communications
December 12, 2024 10:38 PM AEDT| By Team Kalkine MediaHighlights:,First-of-its-kind COVID-19 characterisation trial identifies key blood biomarkers.,Study confirms safety and detailed progression insights of SARS-CoV-2 in human challenge trials.,Early biomarkers show potential for improved infection dia...
HUTCHMED (China) Limited (AIM: HCM; HKEX: 13) Receives Breakthrough Therapy Designation for ORPATHYS® and TAGRISSO® Combination for NSCLC Treatment
December 12, 2024 06:32 PM AEDT| By Team Kalkine MediaHighlights,HUTCHMED's combination of ORPATHYS® and TAGRISSO® receives Breakthrough Therapy Designation (BTD) from NMPA.,Combination treatment aims to address unmet needs in EGFR mutation-positive NSCLC with MET amplification.,Ongoing Phase III SACHI...
Uniphar (LON:UPR) Faces a 1.1% Drop in Stock Price Amid Reduced Trading Volume
December 12, 2024 11:00 AM AEDT| By Team Kalkine MediaHighlights,Uniphar (UPR) shares dropped by 1.1% on Wednesday.,Trading volume significantly decreased by 82%, signaling reduced market activity.,The stock’s 50-day moving average stands at GBX 191.85, indicating a shift in short-term price trends.,Uni...
EKF Diagnostics (LON:EKF) Sees Positive Movement in Stock Price
December 12, 2024 11:00 AM AEDT| By Team Kalkine MediaHighlights,Stock price rose by 0.8%,on Wednesday, showing positive momentum for EKF Diagnostics (EKF).,Increased trading volume by over 1,000%,signals notable interest in the stock.,Key metrics include a market cap of £109.80 million,and a relatively...
Indivior (LON:INDV) Sees Decline Amid Reduced Trading Activity
December 12, 2024 11:00 AM AEDT| By Team Kalkine MediaHighlights,Indivior (INDV) shares fell by 1.2% on Wednesday.,Trading volume saw a drastic drop, with shares down by 81%.,The company faces significant financial indicators that highlight underlying risks.,Indivior PLC (LON:INDV), a leader in the deve...
Genus plc (LON:GNS) Sees Positive Movement Despite Insider Activity
December 11, 2024 11:00 AM AEDT| By Team Kalkine MediaHighlights,Genus (GNS) shares rose by 1.1% on Wednesday.,Shore Capital upgraded Genus to a rating.,Insider Jorgen Kokke sold 2,186 shares at an average price of GBX 1,956.,Genus plc (LON:GNS), a leader in animal genetics, saw its stock rise by 1.1% o...
hVIVO Signs £11.5 Million Contract with Global Pharma Client for RSV Human Challenge Trial
December 10, 2024 07:10 PM AEDT| By Team Kalkine MediaHighlights,hVIVO signs £11.5 million contract with a leading global pharmaceutical client for an RSV challenge trial.,The trial will evaluate an antiviral candidate's safety, pharmacokinetics, and activity, leveraging hVIVO’s FluCamp recruitment arm....
GENinCode Partners with Genesupport to Expand Access to ROCA® Test in Switzerland
December 10, 2024 06:59 PM AEDT| By Team Kalkine MediaHighlights,GENinCode partners with Genesupport SA to expand ROCA® Test availability across Switzerland.,The ROCA Test, recommended by NICE in March 2024, is designed for women at high risk of ovarian cancer.,The collaboration will support over 11,000...
.jpg)
Faron Pharmaceuticals Ltd. (AIM: FARN) Announces Positive Phase 2 Results for BEXMAB in Refractory or Relapsed MDS
December 10, 2024 06:41 PM AEDT| By Team Kalkine MediaHighlights,80% overall response rate (16 out of 20) in refractory/relapsed MDS patient population.,70% of patients achieved complete/partial response, with four progressing to bone marrow transplant.,Webinar scheduled for today to discuss promising B...
EMV Capital Celebrates £1 Million Fundraising for Wanda Connected Health Systems
December 09, 2024 09:47 PM AEDT| By Team Kalkine MediaHighlights,EMV Capital increases its stake in Wanda Connected Health Systems to 21.9%, now valued at £1.35 million.,Wanda secures £1 million to enhance AI algorithms, expand in the US, and seek regulatory approvals.,New partnerships, including with t...
Poolbeg Pharma Showcases Promising Pre-Clinical Results for POLB 001 in Combatting CRS
December 09, 2024 09:47 PM AEDT| By Team Kalkine MediaHighlights,POLB 001 demonstrates significant reduction in Cytokine Release Syndrome (CRS) symptoms in pre-clinical studies.,The therapy outperforms Adalimumab, a standard treatment, in reducing key inflammatory markers.,Pre-clinical findings position...
ValiRx Announces Discounted Share Offering to Fund R&D Initiatives
December 09, 2024 09:27 PM AEDT| By Team Kalkine MediaHighlights,ValiRx plans to raise £1.57 million through a discounted share offering priced at 0.65p per share.,Funds will support preclinical testing, cancer therapy expansion, and new evaluation projects.,Shares fell 46% in early trading, reflecting...
_08_14_2024_19_46_34_162002.jpg)
PureTech Health (LSE: PRTC) Presents Promising Phase 1b Data for LYT-200 in AML and MDS at ASH 2024
December 09, 2024 06:22 PM AEDT| By Team Kalkine MediaHighlights,PureTech unveils favorable Phase 1b data for LYT-200 in relapsed/refractory AML and MDS.,LYT-200 shows clinical benefit, safety, and sustained disease management in heavily pre-treated patients.,Positive results highlight LYT-200’s potenti...
Smith & Nephew Insider Transaction
December 06, 2024 10:44 PM AEDT| By Team Kalkine MediaHighlights,Smith & Nephew (LON:SN) insider Deepak Nath sold 34,033 shares on December 5th.,The company’s stock opened at GBX 978.80 on Friday, with a market cap of £8.53 billion.,Smith & Nephew continues to show solid performance with a PE ratio of 3...
Frasers Group Announces Voluntary Offer for XXL Shares Amid Financial Challenges
December 06, 2024 10:06 PM AEDT| By Team Kalkine MediaHighlights,Frasers Group proposes a voluntary offer of 10 NOK per share, valuing XXL at NOK 246.36 million.,The offer represents a 25% premium to XXL’s closing share price on 5 December.,Frasers plans measures to address XXL’s liquidity issues and su...
AI on the Rise: A Look at Top AI Companies and Their Stocks